ISPC
iSpecimen Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.57
+1.94%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.0x
Market Cap
$3.95M
MomentumView details →
1D Return
+1.94%
YTD Return
−85.29%
RSI (14)
33.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.0x
Market Cap
$3.95M
RSI (14)
33.8
MomentumView details →
1D Return
+1.94%
YTD Return
−85.29%
SummaryUpdated Jun 1, 2026
iSpecimen Inc. (NASDAQ:ISPC) is a biotechnology services company founded in 2009 and headquartered in Lexington, Massachusetts. The company went public in June 2021 through an initial public offering. iSpecimen operates as a technology-enabled marketplace that connects life science researchers with healthcare organizations that have access to human biological specimens needed for medical research and drug development.
Similar companies
Latest newsMore news →
Katharyn Field departed as Chief Executive Officer of iSpecimen Inc., effective 2026-08-26, and was succeeded by Shahin Behroyan.4d agoiSpecimen Inc. received a notice from Nasdaq on May 29, 2026, stating that the company no longer complies with the minimum stockholders' equity requirement under Listing Rule 5550(b)(1).96d ago